Physician profile
Barry D Bertolet
NPI 1295845444
$469,252.57
in general payments reported to CMS, 2019-2025
66 companies · $80K in 2025
The $80K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $95K · 2021: $74K · 2022: $34K · 2023: $67K · 2024: $68K · 2025: $80K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $92K · Consulting Fee: $58K · Travel and Lodging: $29K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $17K · Food and Beverage: $16K · Honoraria: $2,500 · Education: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $92,275.00 |
| Consulting Fee | $58,153.00 |
| Travel and Lodging | $28,513.14 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $16,875.00 |
| Food and Beverage | $15,937.58 |
| Honoraria | $2,500.00 |
| Education | $472.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $172,858.64 | 2021-2025 | Symplicity G3, In.Pact Admiral, Turbohawk |
| Astrazeneca Pharmaceuticals Lp | $87,102.74 | 2019-2025 | Farxiga, Wainua, Andexxa |
| Shockwave Medical, INC | $46,996.67 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $39,895.27 | 2019-2025 | Repatha, Repatha |
| Amarin Pharma, INC. | $34,438.58 | 2019-2021 | |
| Esperion Therapeutics, INC. | $20,047.05 | 2020-2025 | Nexletol, Nexlizet |
| Regeneron Pharmaceuticals, INC. | $11,797.06 | 2019 | |
| Novo Nordisk INC | $9,564.58 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Novartis Pharmaceuticals Corporation | $9,123.40 | 2019-2025 | Leqvio |
| Canon Medical Systems USA, INC. | $6,589.12 | 2023-2024 | Interventional Angiography System, General Non-Equipment, Canon INC. |
| Cardiva Medical, INC. | $4,987.05 | 2020-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Osprey Medical INC | $3,744.38 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $3,233.76 | 2019-2025 | Camzyos, Eliquis |
| Medicure Pharma INC. | $2,325.00 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $2,234.33 | 2019-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder, Gore Viabahn Vbx Balloon Expandable Endo |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,343.35 | 2022-2025 | |
| Boston Scientific Corporation | $1,326.88 | 2019-2025 | General - Vascular Intervention, Lux-Dx Insertable Cardiac Monitor, Opticross 6 |
| Abbott Laboratories | $1,185.53 | 2019-2025 | Xact, Xience Sierra, Navitor |
| Abiomed | $1,139.49 | 2019-2025 | Impella |
| Penumbra, INC. | $957.21 | 2020-2025 | Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $942.68 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $690.62 | 2021-2025 | Verquvo, Capvaxive |
| Endologix LLC | $686.75 | 2024-2025 | Torus Stent Graft System, Endocross Device |
| Philips North America LLC | $546.30 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided, Coronary Other, Mcot |
| Thrombolex, INC. | $486.28 | 2023-2025 | Bashir Endovascular Catheter |
| Bard Peripheral Vascular, INC. | $478.67 | 2019-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Pfizer INC. | $427.97 | 2019-2025 | |
| Biotronik INC. | $404.05 | 2019-2025 | Orsiro Mission |
| Cook Medical LLC | $393.53 | 2019-2025 | Zilver Ptx, Flexor |
| Alnylam Pharmaceuticals INC. | $391.73 | 2024-2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $265.44 | 2019-2022 | |
| Inari Medical, INC. | $262.61 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $224.12 | 2022 | |
| Nuwellis, INC. | $208.49 | 2021-2024 | Aquadex Smartflow Console |
| Chiesi USA, INC. | $178.23 | 2019-2025 | Kengreal, Cleviprex |
| Medtronic Vascular, INC. | $164.37 | 2019-2020 | |
| Inspire Medical Systems, INC. | $139.16 | 2025 | Inspire |
| Celonova Biosciences, INC. | $131.00 | 2019-2020 | |
| Livanova USA, INC. | $129.42 | 2023 | Lifesparc |
| Daxor Corporation | $107.49 | 2023-2024 | Bva-100 |
| Lexicon Pharmaceuticals, INC. | $99.59 | 2024 | |
| Ekos Corporation | $98.23 | 2019 | |
| Irhythm Technologies, INC. | $87.33 | 2019-2023 | Zio Xt Patch |
| Lilly USA, LLC | $87.10 | 2019 | |
| Janssen Scientific Affairs, LLC | $79.96 | 2019 | |
| Terumo Medical Corporation | $78.08 | 2022 | |
| Braemar Manufacturing, LLC | $62.89 | 2019 | |
| Siemens Medical Solutions USA, INC. | $61.05 | 2021 | |
| Silk Road Medical, INC. | $58.64 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Heartflow, INC. | $51.73 | 2022 | |
| Daiichi Sankyo INC. | $47.26 | 2023-2025 | Injectafer |
| Glaxosmithkline, LLC. | $45.27 | 2025 | Shingrix, Arexvy |
| Scpharmaceuticals INC. | $44.03 | 2025 | |
| Edwards Lifesciences Corporation | $38.22 | 2022 | |
| Impulse Dynamics (USA) INC. | $34.71 | 2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.49 | 2023 | Lifevest |
| Sanofi-Aventis U.S. LLC | $32.35 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $24.55 | 2019 | |
| Smith+Nephew, INC. | $16.16 | 2019 | |
| Change Healthcare Technologies, LLC | $11.17 | 2021 | |
| Itamar Medical INC | $10.76 | 2022 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$10,644.67 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Bertolet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.